Cellestia, hope for untreatable cancers.

Hope for untreatable cancers.

Cellestia is a privately-owned
clinical-stage biopharma led by an experienced
team of scientists, drug developers and business professionals.
Our patented drug, CB-103 along with its companion diagnostic, is a small molecule with an innovative mode of action targeting NOTCH-driven cancers, and providing hope for patients with no other treatment options.

WHO WE ARE

We aspire to cure cancer.

WHO WE ARE

We are resolute in our
dedication to patients.

WHO WE ARE

We extend and improve quality of life.

WHO WE ARE

We are relentless in our pursuit of pioneering science.

WHO WE ARE

We do whatever it takes to
adapt to the unknown and
shape the future.

WHO WE ARE

We are all in.

Hope for untreatable cancers.

Cellestia is a privately-owned clinical-stage biopharma led by an experienced
team of scientists, drug developers and business professionals.
Our patented drug, CB-103 along with its companion diagnostic, is a small molecule with an innovative mode of action targeting NOTCH-driven cancers, and providing hope for patients with no other treatment options.

WHO WE ARE

We aspire to cure cancer.

WHO WE ARE

We are resolute in our
dedication to patients.

WHO WE ARE

We extend and improve
quality of life.

WHO WE ARE

We are relentless in our pursuit of pioneering science.

WHO WE ARE

We do whatever it takes to
adapt to the unknown and
shape the future.

WHO WE ARE

Headquarters

Research

Hope for untreatable cancers.

We aspire to cure cancer.

We are resolute in our
dedication to patients.

We extend and improve quality of life.

We are relentless in our pursuit of pioneering science.

We do whatever it takes to
adapt to the unknown and
shape the future.

We are all in.

Hope for untreatable cancers.

We aspire to cure cancer.

We are resolute in our
dedication to patients.

We extend and improve
quality of life.

We are relentless in our pursuit of pioneering science.

We do whatever it takes to
adapt to the unknown and
shape the future.

We are all in.

Headquarters

Research

Hope for untreatable cancers.

We aspire to cure cancer.

We are resolute in our dedication to patients.

We extend and improve quality of life.

We are relentless in our pursuit of pioneering science.

We do whatever it takes toadapt to the unknown andshape the future.

We are all in.

Hope for untreatable cancers.

We aspire to cure cancer.

We are resolute in our dedication to patients.

We extend and improvequality of life.

We are relentless in our pursuit of pioneering science.

We do whatever it takes toadapt to the unknown andshape the future.

We are all in.

We are resolute in our
dedication to patients.

We do whatever it takes to
adapt to the unknown and
shape the future.

We are resolute in our
dedication to patients.

We extend and improve
quality of life.

We do whatever it takes to
adapt to the unknown and
shape the future.